The Exceptional Patient in Cancer Care

NCT00543153 | Completed

• 1 other identifier: 2007-0435
• Study Type: observational
• Target: 13
• Locations: 2 countries
• Sites: 2

Brief Summary

The objectives of this study is to conduct a multicenter, dual country (United States and Israel), study examining the experience of patients with cancer that were considered by their physicians as having exceptional course of survival related to their specific disease state. The primary aim of the study is to develop a detailed description of patients' experience of an exceptional disease course. The secondary aim is to define the content domain for assessment and measurement of exceptional disease course in patients with cancer and identify lessons learned from these exceptional patients that can be a base for future studies to benefit others.

Conditions

Advanced Cancer

Keywords

Advanced Cancer; Exceptional Patient; Cancer Care; Interview

Outcome Measures

Primary Outcomes (1)

• Qualitative Data Collection: Patients' Experience of Exceptional Disease Course

  2 Years

Study Arms (1)

Patients diagnosed with cancer

Behavioral: Interview

Interventions

Interview BEHAVIORAL

Interview lasting approximately 30-45 minutes.

Patients diagnosed with cancer

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients, 18 years of age or older, dianosed with cancer that were considered by their physicians as having exceptional course of survival related to their specific disease state.

You may qualify if:

• years of age or older
• Ability to speak and read English with patients residing in the US, ability to speak and read Hebrew with patients residing in Israel.
• Diagnosis of cancer confirmed by pathology.
• Exceptional disease course as identified by patients' physician, in terms of survival and unusual disease course that is appropriately medically documented.
• Consent to participate in this study.

You may not qualify if:

• Inability to understand the intent of the study.
• Medical condition that would preclude participation in an interview session lasting 30-45 minutes.
• Diagnosis of active psychosis or severe cognitive impairment confirmed by the patient's attending physician.

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead

Study Sites (2)

UT MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Tel Aviv University

Tel Aviv, 64239, Israel

Location

Related Publications (1)

• Frenkel M, Ari SL, Engebretson J, Peterson N, Maimon Y, Cohen L, Kacen L. Activism among exceptional patients with cancer. Support Care Cancer. 2011 Aug;19(8):1125-32. doi: 10.1007/s00520-010-0918-6. Epub 2010 May 29.

  PMID: 20512358 RESULT

Related Links

• The University of Texas M.D.Anderson Cancer Center

MeSH Terms

Interventions

Interviews as Topic

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Moshe A. Frenkel, MD

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 11, 2007
• First Posted: October 12, 2007
• Study Start: August 1, 2007
• Primary Completion: August 1, 2010
• Study Completion: August 1, 2010
• Last Updated: July 30, 2012

Record last verified: 2012-07

Locations

IL (1); US (1)